You are here

  • Home
  • Archive
  • Volume 93, Issue 8
  • Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is necessary

Article Text

Article menu
Download PDFPDF
Letter
Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is necessary
  1. C Pandolfini,
  2. M Bonati
  1. Laboratory for Mother and Child Health, “Mario Negri” Pharmacological Research Institute, Milan, Italy
  1. Chiara Pandolfini, Laboratory for Mother and Child Health, “Mario Negri” Pharmacological Research Institute, Via Giuseppe La Masa 19, 20156 Milan, Italy; pandolfini{at}marionegri.it

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    There is a well-recognised lack of suitable paediatric therapies. This is caused by the great difficulty in performing paediatric clinical trials. However, a recent assessment1 evaluating and comparing ongoing and published paediatric drug-therapy trials found that significant therapeutic research efforts are ongoing.

    The analysis examined data from both clinical trials in the Drug Evaluation in Children (DEC-net) European register of paediatric drug therapy trials2 and published articles, and compared the results with the WHO European Region Top 7 Burden of Disease data …

    View Full Text

    Footnotes

    • Competing interests: None.